Correlation Between AVRO Old and Cns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both AVRO Old and Cns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AVRO Old and Cns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AVRO Old and Cns Pharmaceuticals, you can compare the effects of market volatilities on AVRO Old and Cns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AVRO Old with a short position of Cns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of AVRO Old and Cns Pharmaceuticals.
Diversification Opportunities for AVRO Old and Cns Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between AVRO and Cns is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding AVRO Old and Cns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cns Pharmaceuticals and AVRO Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AVRO Old are associated (or correlated) with Cns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cns Pharmaceuticals has no effect on the direction of AVRO Old i.e., AVRO Old and Cns Pharmaceuticals go up and down completely randomly.
Pair Corralation between AVRO Old and Cns Pharmaceuticals
If you would invest (100.00) in AVRO Old on December 17, 2024 and sell it today you would earn a total of 100.00 from holding AVRO Old or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
AVRO Old vs. Cns Pharmaceuticals
Performance |
Timeline |
AVRO Old |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Cns Pharmaceuticals |
AVRO Old and Cns Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AVRO Old and Cns Pharmaceuticals
The main advantage of trading using opposite AVRO Old and Cns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AVRO Old position performs unexpectedly, Cns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cns Pharmaceuticals will offset losses from the drop in Cns Pharmaceuticals' long position.AVRO Old vs. Ocean Biomedical | AVRO Old vs. Enveric Biosciences | AVRO Old vs. Elevation Oncology | AVRO Old vs. Zura Bio Limited |
Cns Pharmaceuticals vs. ZyVersa Therapeutics | Cns Pharmaceuticals vs. Immix Biopharma | Cns Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | Cns Pharmaceuticals vs. Ocean Biomedical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |